Cargando…

MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism

The MEK5/ERK5 signaling pathway is emerging as an important contributor to colon cancer onset, progression and metastasis; however, its relevance to chemotherapy resistance remains unknown. Here, we evaluated the impact of the MEK5/ERK5 cascade in colon cancer cell sensitivity to 5-fluorouracil (5-F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Diane M., Simões, André E. S., Gomes, Sofia E., Castro, Rui E., Carvalho, Tânia, Rodrigues, Cecília M. P., Borralho, Pedro M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085159/ https://www.ncbi.nlm.nih.gov/pubmed/27144434 http://dx.doi.org/10.18632/oncotarget.9107

Ejemplares similares

MEK5/ERK5 activation regulates colon cancer stem-like cell properties
por: Pereira, Diane M., et al.
Publicado: (2019)

Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
por: Simões, A E S, et al.
Publicado: (2015)

miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells
por: Gomes, Sofia E., et al.
Publicado: (2016)

The MEK5/ERK5 Pathway in Health and Disease
por: Paudel, Rupesh, et al.
Publicado: (2021)

MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation
por: Craig, Jane E., et al.
Publicado: (2020)

Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress
por: Tusa, Ignazia, et al.
Publicado: (2023)

miR-143 Overexpression Impairs Growth of Human Colon Carcinoma Xenografts in Mice with Induction of Apoptosis and Inhibition of Proliferation
por: Borralho, Pedro M., et al.
Publicado: (2011)

Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways
por: Zhang, Weijia, et al.
Publicado: (2023)

Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer
por: Sánchez-Fdez, Adrián, et al.
Publicado: (2021)

MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis
por: Antoon, James W., et al.
Publicado: (2013)

Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells
por: Gomes, Sofia E., et al.
Publicado: (2018)

MEK5/ERK5 Signaling Modulates Endothelial Cell Migration and Focal Contact Turnover
por: Spiering, Désirée, et al.
Publicado: (2009)

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells
por: Tusa, Ignazia, et al.
Publicado: (2021)

MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
por: Fukasawa, Kazuya, et al.
Publicado: (2023)

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
por: Peters, G. J., et al.
Publicado: (1989)

Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: pharmacokinetic evaluation.
por: Boublil, J. L., et al.
Publicado: (1985)

miR-143 over-expression reduces the growth of xenograft tumors from colon carcinoma cells
por: Borralho, Pedro M, et al.
Publicado: (2010)

MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5-fluorouracil in MEK1 Q56P-mutant colorectal cancer cells
por: Jing, Changwen, et al.
Publicado: (2019)

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments
por: Miranda, Mariska, et al.
Publicado: (2015)

In Silico HCT116 Human Colon Cancer Cell-Based Models En Route to the Discovery of Lead-Like Anticancer Drugs
por: Cruz, Sara, et al.
Publicado: (2018)

53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil
por: Li, Xiaoyan, et al.
Publicado: (2013)

Reduced Autophagy in 5-Fluorouracil Resistant Colon Cancer Cells
por: Yao, Cheng Wen, et al.
Publicado: (2017)

ALOX5‐5‐HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation
por: Tang, Jianjun, et al.
Publicado: (2021)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
por: De Angelis, Paula M, et al.
Publicado: (2006)

Patient‐reported skin reactions to 5% 5‐fluorouracil in treatment of actinic keratosis
por: Ahmady, S., et al.
Publicado: (2021)

Porokeratoma treated with topical 5% 5-fluorouracil cream
por: Li, Steve S., et al.
Publicado: (2021)

Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut
por: Bach, S P, et al.
Publicado: (2006)

Sensitization of 5-Fluorouracil-Resistant SNUC5 Colon Cancer Cells to Apoptosis by α-Mangostin
por: Lee, June, et al.
Publicado: (2016)

Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
por: Laudonio, N., et al.
Publicado: (1990)

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients
por: Kandioler, Daniela, et al.
Publicado: (2015)

JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy
por: Sui, Xinbing, et al.
Publicado: (2014)

Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil
por: Subudhi, M. Biswaranjan, et al.
Publicado: (2015)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Adjuvant 5-fluorouracil plus levamisole in colon cancer: the plot thickens?
por: Cassidy, J.
Publicado: (1994)

Hydrogen–water enhances 5-fluorouracil-induced inhibition of colon cancer
por: Runtuwene, Joshua, et al.
Publicado: (2015)

Ceftazidime and cefepime antagonize 5-fluorouracil’s effect in colon cancer cells
por: Pfab, Christina, et al.
Publicado: (2022)

Bioavailability and feasibility of subcutaneous 5-fluorouracil.
por: Borner, M. M., et al.
Publicado: (1993)

5-Fluorouracil Cardiotoxicity: Known But Unknown
por: Brell, Joanna M.
Publicado: (2021)

Efficacy of Topical 5% 5-Fluorouracil with Needling versus 5% 5-Fluorouracil Alone in Stable Vitiligo: A Randomized Controlled Study
por: Zahra, Fatima T., et al.
Publicado: (2020)

Checkpoint Signaling, Base Excision Repair, and PARP Promote Survival of Colon Cancer Cells Treated with 5-Fluorodeoxyuridine but Not 5-Fluorouracil
por: Geng, Liyi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t6vvjqhtd4e1dgqeqn444aon8i